Jakarta, Thekabarnews.com—Indonesia’s Health Minister Budi Gunadi Sadikin has said that the high prices of drugs in the country could mean that the healthcare system is very corrupt.

Budi said not too long ago that drugs in Indonesia might be a lot pricier than drugs in Malaysia and other countries nearby. In addition, he said that the price difference is one of the things that scares people the most. People are most interested in how much drugs cost.

“Prices in Indonesia can be three to five times higher than in Malaysia,” Budi said.

The minister said that this big of a difference could mean that the whole healthcare system is having bigger problems. Therefore, he told the Corruption Eradication Commission (KPK) to check it out and see if there were any issues.

Budi says that the healthcare system may not be honest because drugs cost so much. Such actions could indicate potential systemic corruption affecting pricing and access to necessary medications.

Systemic corruption is when people in a company or organization plan and carry out dishonest acts at many levels.

The Indonesian healthcare system is made up of many different groups. These include the government, hospitals, drug companies, doctors, and health insurance companies.

Budi said that if there is not enough oversight, the industry’s complicated structure can cause problems or mistakes. For example, such issues can include misallocation of resources, increased costs, and compromised patient care.

“Many people work in health care. These are people like drug companies, hospitals, insurance companies, regulators, and medical staff,” he said.

The price of drugs can change for many reasons. Several factors influence drug prices, including import costs, distribution systems, government regulations, and the level of market competition.

The significant price disparity with Malaysia has prompted people to question the transparency and efficiency of Indonesia’s pharmaceutical supply chain. In addition, people worry about access to affordable medicines.

The minister said that one of the government’s main goals is still to lower prices. Budi said that lowering the cost of prescriptions will help more people get medical care and save patients money.

Experts in public health say that to resolve the problem, we would probably have to make significant changes. For example, the government could tighten regulations, increase transparency in drug pricing, and improve oversight of drug procurement.

This investigation into the drug trade could be one of the most important ones in Indonesia in a long time. People who are watching say that this decision could have a big impact on future efforts to make the country’s healthcare system more reliable and affordable.

Stay connected via Google News